EUVIMEDEUVIMED entdecken
Crossref

Enhancing photodynamic and chemodynamic therapy efficacy through a novel ROS-amplifying therapeutic platform for breast cancer treatment

Ning Ding, Qing Yu, Ziyuan Su, Yiting Han, Yajuan Chang, Dongzhi Yang, Shuai Cui, Xu Wang

Nanoscale Horizons · 2026

DOI: 10.1039/d6nh00034g ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale Horizons, 2026. Verfasst von Ning Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, PR China. dongzhiy@xzhmu.edu.cn. Hauptthemen laut MEDLINE: Photochemotherapy, Reactive Oxygen Species, Breast Neoplasms, Photosensitizing Agents. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Xuzhou Municipal Science and Technology Bureau, Jiangsu Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acid-sensitive GOx@MPN@Gel (GOx, luteolin, Fe, MOFs) drives glucose oxidation to fuel enhanced chemodynamic/photodynamic ROS for synergistic cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyReactive Oxygen SpeciesBreast NeoplasmsPhotosensitizing AgentsFemaleHumansAnimalsGlucose OxidaseMiceCell Line, TumorTumor Microenvironment

Substanzen

Reactive Oxygen SpeciesGlucose OxidasePhotosensitizing Agents

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, PR China. dongzhiy@xzhmu.edu.cn.
  • The Second Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221000, PR China. 1173144011@qq.com.
  • The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu 223800, PR China. wangxu19910817@163.com.

Förderung

  • Xuzhou Municipal Science and Technology Bureau
  • Jiangsu Provincial Department of Education

Zitieren

APA

Ding, N., Yu, Q., Su, Z., Han, Y., Chang, Y., Yang, D., Cui, S., & Wang, X. (2026). Enhancing photodynamic and chemodynamic therapy efficacy through a novel ROS-amplifying therapeutic platform for breast cancer treatment. Nanoscale Horizons. https://doi.org/10.1039/d6nh00034g

Vancouver

Ding N, Yu Q, Su Z, Han Y, Chang Y, Yang D, et al. Enhancing photodynamic and chemodynamic therapy efficacy through a novel ROS-amplifying therapeutic platform for breast cancer treatment. Nanoscale Horizons. 2026. doi:10.1039/d6nh00034g

BibTeX
@article{Ding2026,
  author = {Ding, Ning and Yu, Qing and Su, Ziyuan and Han, Yiting and Chang, Yajuan and Yang, Dongzhi and Cui, Shuai and Wang, Xu},
  title = {Enhancing photodynamic and chemodynamic therapy efficacy through a novel ROS-amplifying therapeutic platform for breast cancer treatment},
  journal = {Nanoscale Horizons},
  year = {2026},
  doi = {10.1039/d6nh00034g}
}
Kostenlos starten →